Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

壹立康 - NMPA Drug Approval Details

Approvals/NMPA/Pixavir Marboxil Capsules

Approved

化学药品

Pixavir Marboxil Capsules

健康元药业集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 17, 2025
Approval ID: 8pdZ5467gUe
Company: 健康元药业集团股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8pdZ5467gUe
Approval Number: 国药准字H20250070
Generic Name: 玛帕西沙韦胶囊
Generic Name En: Pixavir Marboxil Capsules
Trade Name: 壹立康
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 20mg
Reg Date: 2025-12-17
Company Name: 健康元药业集团股份有限公司
Company Address: 深圳市南山区高新区北区朗山路17号健康元药业集团大厦
Production Company Name: 凯莱英生命科学技术（天津）有限公司
Production Company Address: 天津开发区第七大街71号
Company Detail Path: /organization/a622e15dcbc67f57/jian-kang-yuan-yao-ye-ji-tuan-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/34ba90aa9e5b7fa6/kai-lai-ying-sheng-ming-ke-xue-ji-zhu-tian-jin-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 17, 2025

Approval ID

8pdZ5467gUe

Type

化学药品

Back to NMPA Approvals